glp 1 and vision loss glp-1 changes Taking a medication? In some cases, changes, like sudden vision Sudden vision loss or blurring

Liraglutide has anti-inflammatory and anti-amyloid properties in Streptozotocin-induced and 5xFAD mouse models of Alzheimers disease

From the perspective of the clinical care of T2D patients who require intensified injection therapy, our findings are consistent with existing treatment guidelines [1, 3] and a real-world study [47], showing that using a GLP-1RA versus insulin therapy has therapeutic benefits in terms of reduced risks of hypoglycemia and all-cause death

Erasing m(6)A-dependent transcription signature of stress-sensitive genes triggers antidepressant actions

Evenly tritium labeled peptides in study of peptide in vivo and in vitro biodegradation

January 2026: Sanofi advanced next-generation insulin formulations aimed at improving glycemic control and patient adherence in long-term diabetes care